{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:41:54Z","timestamp":1753180914401,"version":"3.40.5"},"reference-count":121,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1053\/j.akdh.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:05:07Z","timestamp":1722243907000},"page":"358-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paraprotein-Mediated Glomerular Diseases"],"prefix":"10.1053","volume":"31","author":[{"given":"Jing","family":"Miao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3700-4537","authenticated-orcid":false,"given":"Sandra M.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6573-3325","authenticated-orcid":false,"given":"Zainab","family":"Obaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8988-8998","authenticated-orcid":false,"given":"Tiffany","family":"Caza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-9730","authenticated-orcid":false,"given":"Marco","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1053\/j.akdh.2024.02.005_bib1","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"25","key":"10.1053\/j.akdh.2024.02.005_bib4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1200\/JCO.2008.17.7865","article-title":"Update on treatment recommendations from the fourth international workshop on Waldenstrom\u2019s macroglobulinemia","volume":"27","author":"Dimopoulos","year":"2009","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1053\/j.akdh.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.akdh.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5527\/wjn.v6.i2.72","article-title":"Monoclonal gammopathy of renal significance: diagnostic workup","volume":"6","author":"Correia","year":"2017","journal-title":"World J Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2215\/CJN.00560117","article-title":"Dysproteinemias and glomerular disease","volume":"13","author":"Leung","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1681\/ASN.2012040388","article-title":"Mechanisms of light chain injury along the tubular nephron","volume":"23","author":"Sanders","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2024.02.005_bib11","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1681\/ASN.2020010054","article-title":"Rate and predictors of finding monoclonal gammopathy of renal significance (MGRS) lesions on kidney biopsy in patients with monoclonal gammopathy","volume":"31","author":"Klomjit","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0272-6386(03)00412-8","article-title":"Monoclonal gammopathy: significance and possible causality in renal disease","volume":"42","author":"Paueksakon","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1515\/cclm-2015-0994","article-title":"Laboratory testing in monoclonal gammopathy of renal significance (MGRS)","volume":"54","author":"Leung","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"10.1053\/j.akdh.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/PAS.0b013e3181abdfa7","article-title":"Prevalence and origin of amyloid in kidney biopsies","volume":"33","author":"von Hutten","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1053\/j.ajkd.2019.04.029","article-title":"Dysproteinemia and the kidney: Core Curriculum 2019","volume":"74","author":"Hogan","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mayocp.2018.08.041","article-title":"Incidence of AL amyloidosis in Olmsted county, Minnesota, 1990 through 2015","volume":"94","author":"Kyle","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13023-022-02414-6","article-title":"Global epidemiology of amyloid light-chain amyloidosis","volume":"17","author":"Kumar","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18990-3","article-title":"A population-based cohort study of the epidemiology of light-chain amyloidosis in Taiwan","volume":"12","author":"Hou","year":"2022","journal-title":"Sci Rep"},{"issue":"10","key":"10.1053\/j.akdh.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1681\/ASN.2017121319","article-title":"The complexity and heterogeneity of monoclonal immunoglobulin--associated renal diseases","volume":"29","author":"Sethi","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/modpathol.2017.124","article-title":"Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis","volume":"31","author":"Gibier","year":"2018","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ckj\/sfv087","article-title":"Proteomics and mass spectrometry in the diagnosis of renal amyloidosis","volume":"8","author":"Picken","year":"2015","journal-title":"Clin. Kidney J"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2012.108","article-title":"Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"issue":"15","key":"10.1053\/j.akdh.2024.02.005_bib26","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib27","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/gfr381","article-title":"Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney","volume":"27","author":"Eirin","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.akdh.2024.02.005_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.12688\/f1000research.130285.1","article-title":"A review of recent advances in the diagnosis of cardiac amyloidosis, treatment of its cardiac complications, and disease-modifying therapies","volume":"12","author":"Raval","year":"2023","journal-title":"F1000Res"},{"issue":"9","key":"10.1053\/j.akdh.2024.02.005_bib29","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/ndt\/gfy291","article-title":"AL amyloidosis: advances in diagnostics and treatment","volume":"34","author":"Ry\u0161av\u00e1","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.akdh.2024.02.005_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1163490","article-title":"Editorial: advances in the understanding of pathogenesis, diagnosis, and therapy of light chain amyloidosis","volume":"13","author":"Bhutani","year":"2023","journal-title":"Front Oncol"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ajh.25819","article-title":"Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment","volume":"95","author":"Gertz","year":"2020","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjh.16096","article-title":"Ten-year survivors in AL amyloidosis: characteristics and treatment pattern","volume":"187","author":"Muchtar","year":"2019","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clml.2019.02.009","article-title":"Autologous Hematopoietic cell transplantation versus chemotherapy alone for immunoglobulin light chain amyloidosis: a retrospective study","volume":"19","author":"Miyazaki","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib34","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2017-01-763599","article-title":"Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis","volume":"130","author":"Kaufman","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib36","first-page":"131","article-title":"Future developments in the treatment of AL amyloidosis","volume":"3","author":"Theodorakakou","year":"2022","journal-title":"Hematology"},{"issue":"10","key":"10.1053\/j.akdh.2024.02.005_bib37","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/ndt\/gfp201","article-title":"Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney","volume":"24","author":"Gertz","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"16","key":"10.1053\/j.akdh.2024.02.005_bib38","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1182\/blood-2011-01-330738","article-title":"Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients","volume":"118","author":"Cibeira","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ndt\/gfaa293","article-title":"Renal transplant outcomes in amyloidosis","volume":"36","author":"Law","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib40","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/ndt\/gfr067","article-title":"Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation","volume":"26","author":"Herrmann","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib41","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/TP.0000000000004443","article-title":"Kidney transplantation in patients with monoclonal gammopathy of renal significance","volume":"107","author":"Sprangers","year":"2023","journal-title":"Transplantation"},{"issue":"8","key":"10.1053\/j.akdh.2024.02.005_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41408-022-00714-5","article-title":"Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through the International kidney and monoclonal gammopathy research group","volume":"12","author":"Havasi","year":"2022","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ndt\/gfs492","article-title":"End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases","volume":"28","author":"Tang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib44","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.kint.2020.06.036","article-title":"A study from the Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis","volume":"99","author":"Heybeli","year":"2021","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib45","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/bjh.16246","article-title":"Kidney transplantation in AL Amyloidosis: is it time to maximize access?","volume":"188","author":"Sathick","year":"2020","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2018.09.021","article-title":"Long-term outcome of kidney transplantation in AL amyloidosis","volume":"95","author":"Angel-Korman","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-018-0009-4","article-title":"Cryoglobulinaemia","volume":"4","author":"Roccatello","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000516103","article-title":"Renal disease in cryoglobulinemia","volume":"1","author":"Menter","year":"2021","journal-title":"Glomerular Dis"},{"issue":"9813","key":"10.1053\/j.akdh.2024.02.005_bib49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1053\/j.akdh.2024.02.005_bib50","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2215\/CJN.02980316","article-title":"Lam AQ, American Society of nephrology Onco-nephrology Forum: paraprotein-related kidney disease: glomerular diseases associated with Paraproteinemias","volume":"11","author":"Motwani","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2024.02.005_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820942617","article-title":"Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals","volume":"13","author":"Comarmond","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005792-200209000-00005","article-title":"The clinical and morphologic spectrum of renal cryoglobulinemia","volume":"81","author":"Beddhu","year":"2002","journal-title":"Medicine"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib53","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ajh.24745","article-title":"Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia","volume":"92","author":"Sidana","year":"2017","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib54","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1053\/j.ajkd.2015.12.007","article-title":"AJKD Atlas of renal pathology: cryoglobulinemic glomerulonephritis","volume":"67","author":"Fogo","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.02.005_bib55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ki.2015.195","article-title":"Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits","volume":"88","author":"Larsen","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10067-022-06391-w","article-title":"Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)","volume":"42","author":"Quartuccio","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/1744-9987.13885","article-title":"Cryoglobulinemia and double-filtration plasmapheresis: Personal experience and literature review","volume":"27","author":"Naciri Bennani","year":"2023","journal-title":"Ther Apher Dial"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000534102","article-title":"Efficacy of therapeutic apheresis for cryoglobulinemic vasculitis patients with renal involvement: a systematic review","volume":"53","author":"Miao","year":"2024","journal-title":"Blood Purif"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2006.09.015","article-title":"Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis","volume":"49","author":"Roccatello","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5414\/CNP66395","article-title":"Life-threatening infections following rituximab therapy in renal transplant patients with mixed cryoglobulinemia","volume":"66","author":"Basse","year":"2006","journal-title":"Clin Nephrol"},{"issue":"Suppl 22","key":"10.1053\/j.akdh.2024.02.005_bib61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1399-0012.2010.01281.x","article-title":"A case report of recurrence of mixed cryoglobulinemic glomerulonephritis in a renal transplant recipient","volume":"24","author":"Takeda","year":"2010","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000167955","article-title":"Recurrent essential mixed cryoglobulinemia in renal allografts","volume":"9","author":"Hiesse","year":"1989","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12882-018-0966-6","article-title":"Successful renal transplantation to a recipient with type II cryoglobulinemia: a case report","volume":"19","author":"Kasagi","year":"2018","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib64","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.transproceed.2006.06.131","article-title":"Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients","volume":"38","author":"Basse","year":"2006","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1053\/j.akdh.2024.02.005_bib65","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1093\/ndt\/gfs348","article-title":"Immunotactoid glomerulopathy: clinicopathologic and proteomic study","volume":"27","author":"Nasr","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib66","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.kint.2020.07.037","article-title":"Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants","volume":"99","author":"Nasr","year":"2021","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib67","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.ASN.0000013397.06964.19","article-title":"Immunotactoid glomerulopathy","volume":"13","author":"Schwartz","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib68","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0272-6386(12)70138-5","article-title":"Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy","volume":"22","author":"Fogo","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib69","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1523-1755.2002.00628.x","article-title":"Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features","volume":"62","author":"Bridoux","year":"2002","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.akdh.2024.02.005_bib70","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/ccr3.3044","article-title":"A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab","volume":"8","author":"Kuang","year":"2020","journal-title":"Clin Case Rep"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.kint.2020.06.039","article-title":"Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy","volume":"99","author":"Javaugue","year":"2021","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000440815","article-title":"End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 Consecutive ANZDATA registry cases","volume":"42","author":"Mallett","year":"2015","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2024.02.005_bib73","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.transproceed.2009.03.100","article-title":"A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab","volume":"41","author":"Sathyan","year":"2009","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1053\/j.akdh.2024.02.005_bib74","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2215\/CJN.03870319","article-title":"Fibrillary glomerulonephritis: clinicopathologic features and atypical cases from a multi-institutional cohort","volume":"14","author":"Andeen","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2024.02.005_bib75","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ki.2008.577","article-title":"Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits","volume":"75","author":"Czarnecki","year":"2009","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib76","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.ackd.2022.01.004","article-title":"Monoclonal gammopathy\u2013related kidney diseases","volume":"29","author":"Sy-Go","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.02.005_bib77","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib78","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ekir.2019.04.013","article-title":"Fibrillary glomerulonephritis: an update","volume":"4","author":"Rosenstock","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1681\/ASN.2017050566","article-title":"DnaJ homolog subfamily B member 9 is a putative autoantigen in fibrillary GN","volume":"29","author":"Andeen","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.2017030306","article-title":"DnaJ Heat Shock protein Family B member 9 is a novel biomarker for fibrillary GN","volume":"29","author":"Dasari","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib81","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000455390","article-title":"Clinical features and outcomes of a racially diverse population with fibrillary glomerulonephritis","volume":"45","author":"Payan Schober","year":"2017","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2024.02.005_bib83","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.34067\/KID.0002532020","article-title":"Fibrillary glomerulonephritis and DnaJ homolog subfamily B member 9 (DNAJB9)","volume":"1","author":"Klomjit","year":"2020","journal-title":"Kidney360"},{"issue":"4","key":"10.1053\/j.akdh.2024.02.005_bib84","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.ajkd.2020.01.018","article-title":"Recurrence of DNAJB9-positive fibrillary glomerulonephritis after kidney transplantation: a case series","volume":"76","author":"El Ters","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib85","first-page":"159","article-title":"Outcome of renal transplantation in fibrillary glomerulonephritis","volume":"55","author":"Samaniego","year":"2001","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100445","article-title":"Crystalglobulin-associated kidney disease: a case report and literature review","volume":"4","author":"Leflot","year":"2022","journal-title":"Kidney Med"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib87","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12882-020-01818-5","article-title":"Crystalglobulin-associated nephropathy presenting as MGRS in a case of monoclonal B-cell lymphocytosis: a case report","volume":"21","author":"Gupta","year":"2020","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib88","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2014050509","article-title":"Crystalglobulin-induced nephropathy","volume":"26","author":"Gupta","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib89","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ekir.2018.07.008","article-title":"Paraffin immunofluorescence: a valuable ancillary technique in renal pathology","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"8","key":"10.1053\/j.akdh.2024.02.005_bib90","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00296-020-04620-6","article-title":"Crystalglobulinemia manifested as acute renal failure and thrombotic vasculopathy","volume":"40","author":"G\u00f3mez-Lech\u00f3n Quir\u00f3s","year":"2020","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib91","first-page":"74","article-title":"A case of bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia","volume":"3","author":"Leung","year":"2010","journal-title":"NDT Plus"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.xkme.2019.01.006","article-title":"Crystalglobulin-induced nephropathy and Keratopathy","volume":"1","author":"D\u2019Costa","year":"2019","journal-title":"Kidney Med"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib93","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/ajt.16536","article-title":"Crystalglobulinemia causing cutaneous vasculopathy and acute nephropathy in a kidney transplant patient","volume":"21","author":"Wilson","year":"2021","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib94","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/diagnostics11030420","article-title":"Randall-type monoclonal immunoglobulin deposition disease: New insights into the pathogenesis, diagnosis and management","volume":"11","author":"Cohen","year":"2021","journal-title":"Diagnostics (Basel) [Internet]"},{"issue":"22","key":"10.1053\/j.akdh.2024.02.005_bib95","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib96","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0272-6386(99)70432-4","article-title":"Heavy chain deposition disease: the disease spectrum","volume":"33","author":"Kambham","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib97","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution","volume":"7","author":"Nasr","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib98","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: the disease spectrum","volume":"12","author":"Lin","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"26","key":"10.1053\/j.akdh.2024.02.005_bib99","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1182\/blood-2015-07-658872","article-title":"Natural history and outcome of light chain deposition disease","volume":"126","author":"Sayed","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib100","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib101","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ajh.26566","article-title":"Monoclonal gammopathy of renal significance (MGRS): real-world data on outcomes and prognostic factors","volume":"97","author":"Gozzetti","year":"2022","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.005_bib102","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/bloodadvances.2020001553","article-title":"Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function","volume":"4","author":"Milani","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1053\/j.akdh.2024.02.005_bib103","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ekir.2020.01.011","article-title":"The role of kidney transplantation in monoclonal Ig deposition disease","volume":"5","author":"Angel-Korman","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib104","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1053\/j.ajkd.2021.02.337","article-title":"Kidney transplantation in monoclonal immunoglobulin deposition disease: a report of 6 cases","volume":"78","author":"Molina-And\u00fajar","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0046-8177(85)80017-4","article-title":"Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis","volume":"16","author":"Alpers","year":"1985","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib106","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1523-1755.2004.00365.x","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis","volume":"65","author":"Nasr","year":"2004","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib107","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/ckj\/sfab269","article-title":"An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits","volume":"15","author":"Li","year":"2022","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib108","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ndt\/gfz176","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective","volume":"36","author":"Bridoux","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib109","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/0971-4065.151354","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin deposition disease: the utility of routine staining with immunoglobulin light chains","volume":"25","author":"Gowda","year":"2015","journal-title":"Indian J Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.kint.2018.02.020","article-title":"A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits","volume":"94","author":"Gumber","year":"2018","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib111","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1681\/ASN.2020101541","article-title":"Safety and efficacy of daratumumab in patients with proliferative GN with monoclonal immunoglobulin deposits","volume":"32","author":"Zand","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2024.02.005_bib112","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.kint.2016.02.001","article-title":"The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis","volume":"89","author":"Nasr","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib113","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000498844","article-title":"Monotypic IgG1-kappa atypical anti-glomerular basement membrane nephritis: a case report","volume":"9","author":"Olivier","year":"2019","journal-title":"Case Rep Nephrol Dial"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.005_bib114","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.ajkd.2014.08.022","article-title":"Monoclonal IgG1\u03ba anti-glomerular basement membrane disease: a case report","volume":"65","author":"Coley","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ki.2013.548","article-title":"Membranous-like glomerulopathy with masked IgG kappa deposits","volume":"86","author":"Larsen","year":"2014","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.005_bib116","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ekir.2017.07.008","article-title":"Membranous glomerulopathy with light chain-restricted deposits: a clinicopathological analysis of 28 cases","volume":"2","author":"Best Rocha","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.005_bib117","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy - understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.005_bib118","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.kint.2018.01.037","article-title":"C3 glomerulopathy associated with monoclonal Ig is a distinct subtype","volume":"94","author":"Ravindran","year":"2018","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib119","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ndt\/gfu317","article-title":"Update on C3 glomerulopathy","volume":"31","author":"Barbour","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.005_bib120","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1681\/ASN.2013070715","article-title":"Clinical findings, pathology, and outcomes of C3GN after kidney transplantation","volume":"25","author":"Zand","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2024.02.005_bib121","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41581-023-00766-1","article-title":"The role of complement in kidney disease","volume":"19","author":"Petr","year":"2023","journal-title":"Nat Rev Nephrol"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294981392400048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294981392400048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T10:49:22Z","timestamp":1722250162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294981392400048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S294981392400048X"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2024.02.005","relation":{},"ISSN":["2949-8139"],"issn-type":[{"type":"print","value":"2949-8139"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraprotein-Mediated Glomerular Diseases","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}